CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Prognosis in Patients With Breast Cancer

Wei He* (Corresponding Author), Felix Grassmann, Mikael Eriksson, Erik Eliasson, Sara Margolin, Linda Thorén, Per Hall, Kamila Czene

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Fingerprint

Dive into the research topics of 'CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Prognosis in Patients With Breast Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences